An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo

Craig Cherrin, Hans E. Huber, Bonnie J. Howell et al.|Cancer Biology & Therapy|2010

Cited by 59